期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

促性腺激素释放激素激动剂改善子宫内膜异位症患者生育力的作用机制及应用 被引量：14

The mechanism of action of GnRH agonist to improve the fecundity of women with endometriosis and its application
原文传递
导出
摘要 促性腺激素释放激素激动剂(GnRHa)为治疗子宫内膜异位症(EM)的常用药物之一。EM可多方面对女性生育力产生不利影响,而GnRHa可通过改善EM患者腹腔及卵泡微环境、提高子宫内膜容受性及改善输卵管功能等作用提高EM相关不孕患者生育力,并在联合腹腔镜手术及辅助生殖技术(ART)治疗改善EM不孕患者妊娠结局中具有一定价值。 GnRH agonist（GnRHa） is a kind of medicine most widely used to treat endometriosis.Endometriosis reduces the fecundity of women from many aspects.However,GnRHa can improve the abdominal and follicular environment,receptivity of uterine to embryos and function of oviducts,thus improve the viability of patients with endometriosis.The value of GnRHa treatment in combination with laparoscopic surgery and assisted reproductive technique（ART） to improve the pregnancy outcome of endometriosis is significant to extent.
作者 夏丽群 冯云
机构地区 上海交通大学医学院附属瑞金医院生殖医学中心
出处 《中国优生与遗传杂志》 2011年第4期112-114,共3页 Chinese Journal of Birth Health & Heredity
关键词 促性腺激素释放激素激动剂 子宫内膜异位症 不孕症 GnRH agonist Endometriosis Infertility
分类号 R711.71 [医药卫生—妇产科学]
  • 相关文献

参考文献24

  • 1Dominique DZ, Bruno B, Charles C. Enodmetriosis and infertility: pathophysiology and management[ J]. Lancet,2010,376:730 - 738.
  • 2Tesone M, Bilotas M, Baranao RI, et al. The role of GnRH analogues in endometriosis - associated apoptosis and angiogenssis [ J ]. Gynecol Obstet Invest,2008,66 : 10 - 18.
  • 3Sajal G,Jeffrey MG, Nabil A. Pathogenic mechanisms inendometriosis - associated infertility[ J]. Fertil Steri1,2008 ,90 :247 - 57.
  • 4Yasuko S, et al. Expression in endometriotic stromal cells, probably through nuclear factor - KB activation: gonadotropin releasing hormone agonist treatment reduced IL- 8 expression[ J]. The Journal of Clinical Endocrinology & Metabolism,2003,88:730- 735.
  • 5Sharpe - Timms KL, et al. Tissue inhibitor ofmetallopreteinase - 1 concentrations are attenuated in peritoneal fluid and sera of women with endometriosis and restored in sera by gonadotropin releasing hormone agonist therapy [ J ]. Fertil Steril, 1998,69 : 1128 - 1134.
  • 6Khaleque N K, Michio K, Koichi H, et al. Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy[ J]. Human Reproduction, 2010,25:642 -653.
  • 7Arteaga - Lopez PR, et al. Differential mRNA expression of alpha and beta estrogen receptor isofonns and GnRH in the left and right side of the preoptic and anterior hypothalamic area during the estrous cycle of the rat[ J]. Endocrine,2003,21:251 - 260.
  • 8Ishihara H, Kitawaki J, Kado N, et al. Gonadotropin releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis or leiomyomas[ J]. Fertil Steril,2003 ,79 :735 - 742.
  • 9Heng C R, et al. Ovarian stimulation with GnRH agonist, but not GnRH antagonist, partially restores the expression of endometrial integrin 133 and leukaemia - inhibitory factor and improves uterine receptivity in mice[ J]. Human reproduction,2006,21:2521 - 2529.
  • 10Illera MJ, Juan L, Stewart CL, et al. Effect of peritoneal fluid from women with endometriosis on implantation in the mouse model [ J]. Fertil Steril,2000,?4:41 -48.

同被引文献192

引证文献14

二级引证文献144

中国优生与遗传杂志
2011年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部